Literature DB >> 337635

Bacterial adherence in mastitis caused by Escherichia coli.

J C Anderson, M R Burrows, A J Bramley.   

Abstract

The possible role of bacterial adherence in the pathogenesis of experimental mastitis in the mouse was examined with four strains of Escherichia coli. Two of these strains had a known adhesion antigen (K88) and two did not. The K88 antigen did not play a significant role in the virulence or infectivity of E. coli either in the murine or bovine mammary gland. Two E. coli strains, W1 (K88+) and J2 (K88-) were virulent in the mouse but did not adhere to epithelial cells. Both these strains produced clinical mastitis in the cow. A third strain, D282 (K88-), produced mild disease in the mouse but was avirulent in the cow. The fourth strain, 233/ID (K88+), was avirulent in both the mouse and the cow. Strains D282 and 233/1D were killed rapidly by bovine serum whilst J2 and W1 were more resistant. All strains were more sensitive than the control resistant strain E. coli P4, which is known to be highly virulent for the lactating udder.

Entities:  

Mesh:

Year:  1977        PMID: 337635     DOI: 10.1177/030098587701400608

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  3 in total

1.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

2.  Genomic and Phenomic Study of Mammary Pathogenic Escherichia coli.

Authors:  Shlomo E Blum; Elimelech D Heller; Shlomo Sela; Daniel Elad; Nir Edery; Gabriel Leitner
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

3.  Escherichia coli mastitis strains: In vitro phenotypes and severity of infection in vivo.

Authors:  Perrine Roussel; Adeline Porcherie; Maryline Répérant-Ferter; Patricia Cunha; Christophe Gitton; Pascal Rainard; Pierre Germon
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.